BRIDGEWAY CAPITAL MANAGEMENT, LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 46 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$217,978
-12.9%
149,300
+36.6%
0.01%
-16.7%
Q2 2023$250,297
+72.7%
109,300
-31.4%
0.01%
+50.0%
Q1 2023$144,963
+7.1%
159,3000.0%0.00%0.0%
Q4 2022$135,405
+4.2%
159,3000.0%0.00%
+33.3%
Q3 2022$130,000
-17.7%
159,3000.0%0.00%
-25.0%
Q2 2022$158,000
-39.5%
159,3000.0%0.00%
-20.0%
Q1 2022$261,000
-51.8%
159,300
-29.0%
0.01%
-50.0%
Q4 2021$541,000
-29.8%
224,300
+40.8%
0.01%
-33.3%
Q3 2021$771,000
+37.9%
159,300
-23.9%
0.02%
+50.0%
Q2 2021$559,000
-11.1%
209,300
+2.4%
0.01%
-16.7%
Q1 2021$629,000
+32.1%
204,300
+52.8%
0.01%
+20.0%
Q4 2020$476,000
-11.2%
133,7000.0%0.01%
-16.7%
Q3 2020$536,000
+47.3%
133,7000.0%0.01%
+71.4%
Q2 2020$364,000
+29.1%
133,7000.0%0.01%
+16.7%
Q1 2020$282,000
-61.2%
133,7000.0%0.01%
-40.0%
Q4 2019$727,000
+103.1%
133,700
+50.2%
0.01%
+150.0%
Q1 2019$358,000
+22.6%
89,000
+11.8%
0.00%0.0%
Q4 2018$292,000
-67.4%
79,600
-23.9%
0.00%
-55.6%
Q3 2018$897,000
-3.9%
104,600
+23.1%
0.01%0.0%
Q2 2018$933,000
-4.8%
85,0000.0%0.01%
-18.2%
Q1 2018$980,000
+11.2%
85,0000.0%0.01%
+22.2%
Q4 2017$881,000
-35.0%
85,0000.0%0.01%
-40.0%
Q3 2017$1,355,00085,0000.02%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,749,379$18,147,0003.77%
VR Adviser, LLC 3,427,461$16,589,0002.13%
ADAMS STREET PARTNERS LLC 3,275,616$15,854,0002.04%
Telemetry Investments, L.L.C. 196,168$949,0001.28%
DC Investments Management, LLC 50,709$245,0000.46%
Orbimed Advisors 6,943,654$33,607,0000.37%
EcoR1 Capital, LLC 2,081,077$10,072,0000.35%
BVF INC/IL 1,370,947$6,635,0000.26%
Ikarian Capital, LLC 757,545$3,666,0000.26%
CHI Advisors LLC 165,927$803,0000.23%
View complete list of CORVUS PHARMACEUTICALS INC shareholders